CRO / CMO / CDMO

Delve into the world of CRO / CMO / CDMO in China’s pharmaceutical industry. Fineline Info & Tech provides reliable data, news, and insights on CRO / CMO / CDMO to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

NMPA Proposes Drug Market Exclusivity Framework – Up to Seven Years for Rare Disease Therapies and Two Years for Pediatric Drugs
Policy / Regulatory

NMPA Proposes Drug Market Exclusivity Framework – Up to Seven Years for Rare Disease Therapies and Two Years for Pediatric Drugs

The Comprehensive Department of China's National Medical Products Administration (NMPA) has released the Measures for the Implementation of Drug Market Exclusivity (Draft for Comment), proposing a unified exclusivity regime that…

Mabwell to Present Phase II Data for Nectin‑4 ADC 9MW2821 at ESMO 2026 – 30.0% ORR in Post‑TOP1i‑ADC Triple‑Negative Breast Cancer, Headlining Four Phase III Programs

Mabwell to Present Phase II Data for Nectin‑4 ADC 9MW2821 at ESMO 2026 – 30.0% ORR in Post‑TOP1i‑ADC Triple‑Negative Breast Cancer, Headlining Four Phase III Programs

EMA's CHMP Backs Flexible Dosing for Regeneron's Libtayo – Every‑Six‑Week 700 mg Regimen and Shortened Infusion Options Across All Approved PD‑1 Indications

EMA’s CHMP Backs Flexible Dosing for Regeneron’s Libtayo – Every‑Six‑Week 700 mg Regimen and Shortened Infusion Options Across All Approved PD‑1 Indications

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDeals

Applied Protein Technology Raises Hundreds of Millions in Series B Funding

CompanyDeals

WuXi ATU Licenses TESSA Technology to Janssen Biotech for AAV Production

CompanyDeals

Sinotherapeutics Inc. to Raise RMB600m via STAR Board IPO for Generic Drug Expansion

CompanyDeals

BioDuro-Sundia and X-Chem Form Long-Term Partnership for Drug Discovery

CompanyLegal / IP

Transcenta Appoints Dr. Caroline Germa as Global Drug Development Chief

CompanyDeals

Intellective Biologics Raises Over RMB500m in Series C Financing Round

CompanyDeals

Shanghai Pharmaceuticals Partners with HKSTP and Shanghai Biomedicine Fund on R&D Collaboration

CompanyDeals

WuXi Biologics Partners with AstraZeneca for Local Production of Evusheld

Show More